EIGR(Delisted)
EigerยทNASDAQ
--
--(--)
EIGR Profile
Eiger Biopharmaceuticals, Inc.
A commercial-stage biopharmaceutical company that develops innovative therapies for hepatitis delta virus (HDV) and other serious diseases
2155 Park Boulevard, Palo Alto, CA 94306
--
Eiger BioPharmaceuticals, Inc., was formed by the merger of Celladon Corporation and BioPharmaceuticals, Inc., on March 22, 2016. BioPharmaceuticals, Inc., incorporated in California, USA on December 21, 2000 and re-merged in Delaware in April 2012, is a commercial-stage biopharmaceutical company focused on developing innovative therapies for delta virus (HDV) and other serious diseases. In their portfolio, all of their rare disease programs are designated as breakthrough therapies by the U.S. Food and Drug Administration.
